Anzeige
❌
Mehr »
Samstag, 26.09.2026 - Börsentäglich über 12.000 News
GALLIUM WAR NUR DER ANFANG: Atlanticos Vier-Metall-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
426 Leser
Artikel bewerten:
(2)

IMA: IMA and HFMA Release Report on Cost Management in Healthcare

Recommendations aim to help accounting and finance professionals modernize data analysis and strategic insight generation

MONTVALE, NJ / ACCESSWIRE / May 23, 2023 / As the complexities faced by one of the largest and most essential industries continue to rise, IMA® (Institute of Management Accountants) and the Healthcare Financial Management Association (HFMA), today released "Cost Management in Healthcare: Status Quo and Opportunities." The joint report acknowledges the challenges, identifies opportunities, and presents actionable recommendations for accounting and finance leaders to help healthcare institutions improve quality while lowering costs.

Through roundtable discussions with 20 leaders in financial management, accounting, and analytics roles, IMA and HFMA sought to examine the role of management accounting in the U.S. healthcare industry. The resulting report reveals a growing business demand for the finance function to deliver greater value through efficient data analysis and strategic insight generation with recommendations on how to prepare teams to meet current and future demands.

"Many healthcare providers are focused on developing value-based care models and other risk arrangements, causing a challenge on the finance side," said Richard Gundling, CMA, FHFMA, senior vice president of professional practice at HFMA. "However, for providers to deliver value in healthcare, they must have accurate, actionable data on the two elements driving the value equation: quality of the care delivered and cost of providing the care. Our report offers key recommendations on how institutions can link quality and cost metrics to quantify the value of care provided."

To achieve optimal financial and value outcomes for healthcare institutions, the research shows how healthcare's finance function can upskill its workforce to become analytical thinkers, bolster data accessibility and integration for strategic decision-making, and contribute to the advancement of health equity.

"Strained resources and limited adoption of advanced technologies and data analytics tools continue to cause prevailing challenges for healthcare institutions," said Loreal Jiles, vice president of research and thought leadership at IMA. "However, championing modernization can enable institutions to collect insights based on real-time data, support the resolution of complex issues across business lines from an analytical perspective, and use financial data for cross-functional collaborations."

The accounting and finance function continues to play an increasingly pivotal role as the healthcare industry progressively shifts toward value-based delivery. As such, finance teams must modernize current cost practices to meet the demanding industry needs of quality, value, and low cost.

For more information, visit: https://www.imanet.org/research-publications/ima-reports/Cost-Management-In-Healthcare-Status-Quo-and-Opportunities

About IMA® (Institute of Management Accountants)
IMA® is one of the largest and most respected associations focused exclusively on advancing the management accounting profession. Globally, IMA supports the profession through research, the CMA® (Certified Management Accountant) and CSCA® (Certified in Strategy and Competitive Analysis) programs, continuing education, networking, and advocacy of the highest ethical business practices. Twice named Professional Body of the Year by The Accountant/International Accounting Bulletin, IMA has a global network of about 140,000 members in 150 countries and 350 professional and student chapters. Headquartered in Montvale, N.J., USA, IMA provides localized services through its four global regions: The Americas, Asia/Pacific, Europe and Middle East/India. For more information about IMA, please visit www.imanet.org.

About HFMA (Healthcare Financial Management Association)

HFMA equips its more than 100,000 members nationwide to navigate a complex healthcare landscape. Finance professionals in the full range of work settings, including hospitals, health systems, physician practices, and health plans, trust HFMA to provide the guidance and tools to help them lead their organizations, and the industry, forward. HFMA is a not-for-profit, nonpartisan organization that advances healthcare by collaborating with other key stakeholders to address industry challenges and providing guidance, education, practical tools and solutions, and thought leadership. We lead the financial management of healthcare. For more information about HFMA, please visit www.hfma.org.

CONTACT:

Brian Sherry
Stern Strategy Group
908-325-3860
ima@sternstrategy.com

Brad Dennison
HFMA
630-386-2945
bdennison@hfma.org

SOURCE: IMA® (Institute of Management Accountants)

View source version on accesswire.com:
https://www.accesswire.com/756636/IMA-and-HFMA-Release-Report-on-Cost-Management-in-Healthcare

© 2023 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.